| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:37 UTC |
|---|
| HMDB ID | HMDB0014433 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Amcinonide |
|---|
| Description | Amcinonide is only found in individuals that have used or taken this drug. It is a corticosteroid.The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Amcinonide has affinity for the glucocorticoid receptor. It has weak affinity for the progesterone receptor, and virtually no affinity for the mineralocorticoid, estrogen, or androgen receptors. |
|---|
| Structure | [H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC1(CCCC1)O2)C(=O)COC(C)=O InChI=1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Amcinonida | ChEBI | | Amcinonidum | ChEBI | | Triamcinolonacetatcyclopentanonid | ChEBI | | Cyclocort | Kegg | | Fujiwasa brand OF amcinonide | HMDB | | Pharmadéveloppement brand OF amcinonide | HMDB | | Triamcinolone 16,17-cyclopentylidenedioxy-21-acetate | HMDB | | Amcininide | HMDB | | Hermal brand OF amcinonide | HMDB | | Stiefel brand OF amcinonide | HMDB | | Amciderm | HMDB | | Penticort | HMDB | | Cyclort | HMDB | | Taro brand OF amcinonide | HMDB |
|
|---|
| Chemical Formula | C28H35FO7 |
|---|
| Average Molecular Weight | 502.5717 |
|---|
| Monoisotopic Molecular Weight | 502.236681679 |
|---|
| IUPAC Name | 2-[(1'S,2'S,4'R,8'S,9'S,11'S,12'R,13'S)-12'-fluoro-11'-hydroxy-9',13'-dimethyl-16'-oxo-5',7'-dioxaspiro[cyclopentane-1,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',17'-dien-8'-yl]-2-oxoethyl acetate |
|---|
| Traditional Name | amcinonide |
|---|
| CAS Registry Number | 51022-69-6 |
|---|
| SMILES | [H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC1(CCCC1)O2)C(=O)COC(C)=O |
|---|
| InChI Identifier | InChI=1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1 |
|---|
| InChI Key | ILKJAFIWWBXGDU-MOGDOJJUSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Pregnane steroids |
|---|
| Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Progestogin-skeleton
- 20-oxosteroid
- 3-oxo-delta-1,4-steroid
- 3-oxosteroid
- 9-halo-steroid
- Halo-steroid
- Hydroxysteroid
- Oxosteroid
- 11-beta-hydroxysteroid
- 11-hydroxysteroid
- Delta-1,4-steroid
- Alpha-acyloxy ketone
- Ketal
- Cyclic alcohol
- Meta-dioxolane
- Secondary alcohol
- Cyclic ketone
- Carboxylic acid ester
- Fluorohydrin
- Halohydrin
- Ketone
- Organoheterocyclic compound
- Oxacycle
- Carboxylic acid derivative
- Acetal
- Monocarboxylic acid or derivatives
- Organofluoride
- Organic oxygen compound
- Organooxygen compound
- Carbonyl group
- Alkyl fluoride
- Alkyl halide
- Organic oxide
- Alcohol
- Hydrocarbon derivative
- Organohalogen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0077 g/L | Not Available | | LogP | 2.3 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.3 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 18.8135 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.17 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3349.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 301.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 234.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 184.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 248.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 871.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 732.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 89.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1677.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 625.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1895.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 555.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 539.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 259.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 415.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Amcinonide,1TMS,isomer #1 | CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C)C[C@@]12C | 3740.0 | Semi standard non polar | 33892256 | | Amcinonide,1TMS,isomer #2 | CC(=O)OC=C(O[Si](C)(C)C)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C | 3819.3 | Semi standard non polar | 33892256 | | Amcinonide,2TMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C)C[C@@]12C | 3756.6 | Semi standard non polar | 33892256 | | Amcinonide,2TMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C)C[C@@]12C | 3664.4 | Standard non polar | 33892256 | | Amcinonide,2TMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C)C[C@@]12C | 4302.4 | Standard polar | 33892256 | | Amcinonide,1TBDMS,isomer #1 | CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]12C | 3990.8 | Semi standard non polar | 33892256 | | Amcinonide,1TBDMS,isomer #2 | CC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C | 4062.1 | Semi standard non polar | 33892256 | | Amcinonide,2TBDMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]12C | 4235.2 | Semi standard non polar | 33892256 | | Amcinonide,2TBDMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]12C | 4103.0 | Standard non polar | 33892256 | | Amcinonide,2TBDMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]12C | 4469.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Amcinonide GC-MS (Non-derivatized) - 70eV, Positive | splash10-00u6-3971300000-7cbdc8c059dd4f5822ad | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Amcinonide GC-MS (1 TMS) - 70eV, Positive | splash10-0a5c-6943140000-2279895eed264788ee3b | 2017-10-06 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Amcinonide , positive-QTOF | splash10-024i-3891000000-ef24dafd204a6e82ead7 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amcinonide 50V, Positive-QTOF | splash10-0229-0690000000-3c84a7059d4e51b29aa1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amcinonide 30V, Positive-QTOF | splash10-03mu-0395000000-56d931787f3e3cbb4e86 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amcinonide 50V, Positive-QTOF | splash10-0229-0690000000-e28ac629dab1bb357a9e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amcinonide 40V, Positive-QTOF | splash10-024i-0491000000-8009a1d8e6a2892a7614 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amcinonide 10V, Positive-QTOF | splash10-0ue9-0006890000-53d068311194c6b17fad | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amcinonide 40V, Positive-QTOF | splash10-024i-0491000000-8d071ff2760e47bfc523 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amcinonide 20V, Positive-QTOF | splash10-007c-0149200000-06ecc6219678a9bb9484 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 10V, Positive-QTOF | splash10-0udu-3010930000-34efff6124c7abe1a311 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 20V, Positive-QTOF | splash10-0kbf-4130900000-08e4a8952bc3ea9fa0ad | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 40V, Positive-QTOF | splash10-0a4l-9010000000-e82bdf9889f68e638b35 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 10V, Negative-QTOF | splash10-0pb9-9002440000-85f05d77fa6c5f2baa12 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 20V, Negative-QTOF | splash10-0a4i-9001300000-d85b1f34e444142a5908 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 40V, Negative-QTOF | splash10-0a4i-9002100000-71a731aca133e5aa6e88 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 10V, Negative-QTOF | splash10-0zfr-5000390000-9146d5d9dfaa0edaa2db | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 20V, Negative-QTOF | splash10-0a4i-9000000000-c01bbbf5bed889264ddb | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 40V, Negative-QTOF | splash10-0a4l-9100200000-3da327bc42dd03a5551c | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 10V, Positive-QTOF | splash10-0ue9-0002940000-de822404ebb2908f48b3 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 20V, Positive-QTOF | splash10-0udi-0311930000-193c52b2bd0f3ca5b8c7 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amcinonide 40V, Positive-QTOF | splash10-00ej-1970000000-9b48e6e1df4e2352ecf2 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|